Table 1.
Method | Advantages | Disadvantages | Ref. | |
---|---|---|---|---|
Active Delivery | Iontophoresis |
• Improving the delivery of polar molecules as well as high molecular weight compounds • Faster and easier administration • Enabling continuous or pulsatile delivery of drug |
• Risk of burns if electrodes are used improperly • Difficulty stabilizing the therapeutic agent in the vehicle • Complexity of the drug release system |
[25–29] |
Sonophoresis |
• Allows strict control of transdermal diffusion rates • In many cases, greater patient approval • Less risk of systemic absorption • Helpful to break up blood clots • Not immensely sensitizing |
• Can be prolonged to administer • Minor tingling, irritation and burning • SC must be unbroken for effective drug penetration |
[30–33] | |
Electroporation |
• Highly effective, reproducible, directed drug transfer • Permits rapid termination of drug delivery through termination • Not immensely sensitizing |
• Impossible to use on a large area • Can be disturb the cargo if high voltage is uesd • Possibility of cell damage • Relatively nonspecific |
[34–36] | |
Photomechanical waves |
• Can improve transfer of molecules across the plasma membrane of cells in vitro without loss of viability • Not appear to cause injury to the viable skin • Do not cause pain or discomfort |
• Lack of human clinical data | [37–40] | |
Microneedle |
• Painless administration of the active pharmaceutical ingredient • Faster healing at injection site • No fear of needle • Specific skin area can be targeted for proper drug delivery |
• Lower dosing accuracy than hypodermic needles • Penetration depth of various particles depending on the skin layer • Possibility of venous collapse due to repeated injections |
[41–54] | |
Thermal ablation |
• Avoid the pain, bleeding, and infection • Can remove SC selectively without damaging deeper tissues • Better control and reproducibility • Low cost and disposable device |
• Structural changes in the skin must be evaluated • Existing concerns about the use of extreme temperatures and the logistics of such devices |
[55–59] | |
Passive delivery | Vesicles |
• Accomplish sustained drug release behavior • Control the absorption rate through a multilayered structure |
• Chemically unstable • Expensive of formulations • Limitation of drug loading |
[60–63] |
Polymeric nanoparticles |
• Accomplish targeted and controlled release behavior • High mechanical strength and non-deformability • Can be made of various biodegradable materials • Can be loaded both hydrophilic and hydrophobic drugs • Can avoid the immune system due to small size |
• Difficult to break down • Not enough toxicological assessment has been done • Some processes are difficult to scale up |
[64-70] | |
Nanoemulsion |
• Long-term thermodynamic stability • Excellent wettability • High solubilization capacity and physical stability • Possible to formulate it in variety of formulations |
• Requires large concentration of emulsifiers • Limited solubilizing capacity for high-melting substances • Variable kinetics of distribution processes and clearance |
[58, 71, 72] |